Hyprosafe 250mg Injection
By Hyprosafe
Rx
1 Powder for Injection in a Vial

Composition
Hydroxyprogesterone(250mg)

Manufacturer - BMW Pharmaco India Pvt. Ltd.
BMW HOUSE 15/3, BMW Street, Lalpur Road, Gwarighat, Jabalpur - 482008 Madhya Pradesh, India

Expires on or after
October, 2025

liver
Caution should be taken while using Hyprosafe 250mg Injection in individuals with liver disease, as it may be unsafe for them. Patients with liver issues are advised to avoid using this medication. It is highly recommended to consult with your doctor before starting treatment with Hyprosafe 250mg Injection to assess the potential risks and benefits specific to your liver condition.

kidney
Limited information is available on the use of Hyprosafe 250mg Injection in patients with kidney disease. Consult your doctor. The medicine contains progesterone which may cause fluid retention in those with kidney issues.

alcohol
Consult your doctor when consuming alcohol with Hyprosafe 250mg Injection.

driving
Hyprosafe 250mg Injection typically does not impact driving ability.

pregnancy
Hyprosafe 250mg Injection is generally safe in pregnancy, based on animal studies with minimal adverse effects on the baby. Limited human studies are available.

breastfeeding
Hyprosafe 250mg Injection is considered safe for breastfeeding. Studies show minimal transfer into breastmilk, posing no harm to the baby.
Habit Forming | No |
Chemical Class | Gluco/Mineralocorticoids, Progestogins Derivatives |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | Progestins (First generation) |
₹81
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024